// App-Quantinova.ai

FP12.04 : Obesity is Associated With Greater Overall Survival in Patients With Metastatic NSCLC Receiving First-Line Pembrolizumab

Researchers

Presenter

  • F. Thomson

Principal Investigators

  • S. Campbell

  • A. Tufail

  • T. Evans

  • M. Stares

Medical Centers

  • Medical School, University Of Edinburgh, Edinburgh, UK

  • Edinburgh Cancer Centre, Edinburgh, Scotland/GB

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

Disease

  • Obesity

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

  • Body mass index

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved